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Abstract
The syndecans, heparan sulfate proteoglycans, are abundant mol-
ecules associated with the cell surface and extracellular matrix and
consist of a protein core to which heparan sulfate chains are covalently
attached. Each of the syndecan core proteins has a short cytoplasmic
domain that binds cytosolic regulatory factors. The syndecans also
contain highly conserved transmembrane domains and extracellular
domains for which important activities are becoming known. These
protein domains locate the syndecan on cell surface sites during
development and tumor formation where they interact with other
receptors to regulate signaling and cytoskeletal organization. The
functions of cell surface heparan sulfate proteoglycan have been
centered on the role of heparan sulfate chains, located on the outer side
of the cell surface, in the binding of a wide array of ligands, including
extracellular matrix proteins and soluble growth factors. More re-
cently, the core proteins of the syndecan family transmembrane
proteoglycans have also been shown to be involved in cell signaling
through interaction with integrins and tyrosine kinase receptors.
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Introduction
Proteoglycans are molecules composed
of a protein core to which glycosaminogly-
can chains are covalently attached. The syn-
decans consist of a family of highly con-
served type I transmembrane heparan sulfate
proteoglycans that are expressed in a devel-
opmental and cell type-specific pattern (1-
4). The amino-terminal sequence of the core
protein is followed by an ectodomain con-
taining Ser-Gly consensus sequences for gly-
cosaminoglycan attachment, a single highly
conserved transmembrane domain and a short
highly conserved cytoplasmic domain. All
syndecan proteins carry heparan sulfate
chains, and some core proteins can be addi-
tionally substituted with chondroitin sulfate
chains (5). The expression of the syndecans
can be altered under certain pathophysiologi-
cal conditions, including the processes of
tumor onset, progression and metastasis (6,7).
Many reports have suggested that heparan
sulfate proteoglycans play a role in growth
control, cell spreading, cellular recognition,
cellular adhesion, and signaling, possibly as
co-receptors with integrins and cell-cell ad-
hesion molecules, including fibronectin, vi-
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tronectin, laminins, and the fibrillar colla-
gens (1-3,8-12). In addition, several papers
have described high affinity association of
heparin-like molecules with growth factors,
implying that the effects of heparan sulfate
on cell growth are likely to be mediated by
growth factors (13-18). This review focuses
on the possible roles of syndecan core pro-
teins and heparan sulfate chains in cell sig-
naling.
Structure of syndecans
The syndecan core proteins consist of a
family of four distinct genes in vertebrates.
The data regarding the sequence of Droso-
phila syndecan as well as chromosomal lo-
cations and exon organization, suggest that
the gene family arose by gene duplication
and divergent evolution from a single ances-
tral gene, and that syndecan-1 and -3 and
syndecan-2 and -4 represent subfamilies.
Each gene product is a single type I mem-
brane-spanning protein with an apparently
extended extracellular domain of varying
size that contains covalently attached hepa-
ran sulfate chains distal from the plasma
membrane (3) (Figure 1).
The syndecans are membrane proteins
that do not contain cysteine residues and
show few but important structural similari-
ties. Structural variabilities are mainly found
in the extracellular domains (ectodomains),
that are among the most rapidly diverging
vertebrate proteins with the exception of
their regions for GAG attachment, cell inter-
action, proteolytic cleavage site, and oligo-
merization. These domains contain se-
quences of Ser-Gly-X-Gly preceded by an
acidic amino acid, being consensus sequences
for the glycosylation of heparan sulfate
chains. Also, protease cleavage sites com-
posed of basic amino acids are found close
to the transmembrane portion of the protein
core and are related to shedding of the pro-
teoglycan from the cell surface (Figure 1).
The transmembrane domains are relatively
stable evolutionarily, since only a few amino
acids differ among the vertebrate sequences.
These domains contain regions for interac-
tions with other membrane proteins and for
localization to distinct membrane compart-
ments.
The cytoplasmic domains contain two
invariant regions, a membrane proximal com-
mon region (C1) containing a serine and a
tyrosine and a C-terminal common region
(C2), separated by a region (V) of variable
length and composition (Figures 1 and 2).
The C2 region shows an EFYA sequence at
the C-terminus that can bind to the PDZ
domain present in specific proteins. PDZ
domains, named for PSD-95, Discs-large,
and Zonula occludens-1 proteins, bind spe-
cific C-terminal sequences and organize and
assemble protein complexes on the inner
surface of the plasma membrane and are
thought to link membrane components to the
underlying actin-containing cytoskeleton
(Figure 2). The variable (V) region is dis-
tinct for each of the 4 family members, but
its syndecan specific identity is conserved
across species (3). The function of this do-
main is largely unknown except for syndecan-
4, where it is responsible for the assembly of
Figure 1. Schematic representation of mammalian syndecans. The proteins are aligned at
the signal peptides and the transmembrane domains, leaving gaps in the ectodomains. The
glycosaminoglycan attachment sites are indicated as black lines. Syndecans contain a
conserved transmembrane domain and a small cytoplasmic domain consisting of one
variable (V) and two conserved (C1 and C2) regions.
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syndecan-4 tetramers with phosphatidylino-
sitol 4,5-bisphosphate (PIP2) and activated
protein kinase C-α (PKC-α) in focal adhe-
sions (19,20).
Dramatic changes in syndecan expres-
sion occur during development and are asso-
ciated with morphological transitions, cell
differentiation, or changes in tissue organi-
zation (21).
Syndecans in cell adhesion
Intact proteoglycan is mandatory for cell
adhesion and migration since these processes
require both heparan sulfate-ligand binding
and interactions of the core protein with
cytoskeletal and/or signaling molecules. The
cytoplasmic domain of syndecan interacts
with a number of signaling and structural
proteins, and both extracellular and cyto-
plasmic domains are necessary for the acti-
vation of transmembrane receptors. All mam-
malian syndecan cytoplasmic domains con-
tain a conserved EFYA sequence at the C-
terminus, which can bind PDZ domain-con-
taining scaffold proteins (CASK and synte-
nin) and coordinate clustering of receptors
and connection to the actin cytoskeleton (Fig-
ure 2). As already mentioned, proteins bear-
ing the PDZ domain are implicated in orga-
nizing signaling complexes at specific sites
of the membrane, such as cell junctions (20,
22).
In vitro studies indicate that all synde-
cans can interact with CASK, and may form
similar complexes in different contexts.
CASK forms a ternary complex with synde-
can-2 and protein 4.1, possibly linking the
extracellular membrane and the cytoskel-
eton (23). Syndecan-2 and CASK co-local-
ize in rat brain neuronal synapses, suggest-
ing involvement in signaling at synaptic junc-
tions (24). This complex also seems to be
crucial for maturation of dendritic spines of
rat hippocampal neurons (25).
The involvement of proteoglycans in cy-
toskeletal organization has been proposed in
Figure 2. Syndecan core protein structure. The extracellular domains of the four vertebrate
syndecans contain several sites for heparan sulfate chain attachment. The transmembrane
domain is highly conserved among the family members. The cytoplasmic domains contain
regions (C1 and C2) that are exactly conserved in each of the four syndecans (the
exception being a conservative substitution of arginine for lysine in syndecan-2). These
flank a central variable (V) region that is distinct for each family member. Synd = syndecan.
other studies (19,26). Cell spreading is pro-
moted by over-expression of syndecan-1 that
transiently co-localizes with microfilaments.
Thrombospondin-1 functions as a cell adhe-
sion molecule and also regulates cell adhe-
sion to other matrix components. Syndecan-
1, together with F-actin and fascin, is in-
volved in signal transduction of cells spread-
ing on thrombospondin-1 (27). Syndecan-2
is found on the actin-rich dendritic spines
and may be responsible for the morphologi-
cal maturation of spines from long thin pro-
trusions to stubby headed shapes (28). Syn-
decan-3 in Schwann cells mediates cell ad-
hesion and spreading on a novel heparan
sulfate binding site located at the N-terminal
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domain of type V collagen (α4 chain). This
process leads to actin assembly, tyrosine
phosphorylation, as well as activation of the
Erk1/Erk2 protein kinases (29).
The best evidence for a specific role of
syndecans in cell adhesion comes from stud-
ies of focal adhesion formation. Focal adhe-
sions are specialized zones of tight cell-
matrix interaction located at the termini of
actin stress fibers, and are important signal-
ing centers, where integrins and heparan
sulfate proteoglycans cooperate to connect
extracellular matrix and cytoskeleton (30,31)
(Figure 3).
Syndecan-4 is a peculiar transmembrane
heparan sulfate proteoglycan present together
with integrins in focal adhesion on different
substrates (fibronectin, laminin, vitronectin,
or type I collagen) of a number of cell types.
The syndecan-4 C1 and V regions bind
syndesmos, a paxillin-binding protein that
may serve to link syndecan-4 to the cyto-
skeleton. α-Actinin has also been recently
shown to bind the V region of syndecan-4
(19).
Primary fibroblasts attach and spread fol-
lowing integrin ligation, but do not form
focal adhesions in the absence of a heparin-
biding domain of fibronectin, implying re-
quirement of heparan sulfate proteoglycan
(3,19,32). Recruitment of syndecan-4 into
focal adhesions may be dependent on acti-
vation of PKC. A connection was estab-
lished between the V region of syndecan-4
and PKC-α localization and activation, con-
sistent with a role for this kinase in fibroblast
focal adhesion assembly (19,32).
Syndecan-4 and PKC activation
A family of serine/threonine kinases col-
lectively known as PKC are involved in the
regulation of a variety of cell functions in-
cluding proliferation, gene expression, cell
cycle, differentiation, cytoskeletal organiza-
tion, cell migration, cell adhesion, and apop-
tosis. In the syndecan family, syndecan-4 is
the one related to PKC activation. Syndecan-
4 cytoplasmic domain interacts with PKC-α
(19,32-34) and activates its kinase activity
in the presence of PIP2 in vitro (21,34). In
vivo, syndecan-4 also interacts with PKC-α
and this interaction regulates localization of
PKC-α into the cytoskeleton, resulting in a
sustained PKC activity (34).
Oligomerization of syndecan-4 cytoplas-
mic domains results from the interaction
with PIP2 (32). Studies have shown that the
dimer formed by the syndecan-4 V region
can bind PIP2 and is stabilized by the inter-
action (35). However, the number of dimers
and PIP2 molecules involved in a single
signaling complex remains to be determined.
Nevertheless, it is clear that oligomerization
of the syndecan-4 proteoglycan not only
drives focal adhesion formation but also pro-
vides a platform for the binding and activa-
tion of PKC-α (Figure 3).
Figure 3. Some of the activities involving syndecans. Syndecans modulate growth factor
signaling (A) and participate in cell adhesion (B). A, Binding to syndecans can regulate
growth factor interactions with tyrosine kinase receptors. The model shows heparan sulfate
(HS) chains mediating dimerization of fibroblast growth factor (FGF)-2 and subsequently
FGF receptors (FGFR), promoting the formation of a signaling complex and tyrosine kinase
signal transduction. Multiple syndecans were shown to support FGF biological activities. B,
Focal adhesion is a specialized membrane complex in which integrins and syndecan
cooperate to connect extracellular matrix and cytoskeleton. The syndecan involved ap-
pears to be exclusively syndecan-4. PIP2 = phosphatidylinositol 4,5-bisphosphate; PKC-α
= protein kinase C-α.
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Work with fusion proteins and synthetic
peptides shows that oligomerized, but not
monomeric, cytoplasmic domains of synde-
can-4 can bind PKC-α directly through the
PKC-α catalytic domain, which in turns re-
sults in direct activation of PKC-α in the
absence of other mediators and superactiva-
tion in their presence. The combination of
the syndecan-4 cytoplasmic domain, PIP2
and PKC-α yields a potent signaling com-
plex, in which levels of PKC-α activity are
as high as can be achieved using conven-
tional activators. The signaling activity of
the cytoplasmic tail of syndecan-4 seems to
be supported by PIP2 that serves as a binding
interface, an essential co-factor for PKC-α
activation and a facilitator for the multimer-
ization of the tail (33-36). These properties
are regulated by the phosphorylation of a
specific serine residue located close to the
N-terminus of the PIP2 binding motif (35).
PKC-δ, rather than PKC-α that associates
with the domain in focal adhesions, appears
to be responsible for the phosphorylation
event (36). Once phosphorylated, the af-
finity of the cytoplasmic tail for PIP2 and its
capacity to oligomerize and activate PKC-α
in the presence of PIP2 are sharply reduced
(33). The association of syndecan-4 with
PKC-α puts the proteoglycan in a category
similar to other transmembrane receptors,
such as integrin, which do not possess intrin-
sic catalytic activity, but are associated with
kinases or phosphatases.
Syndecans and growth factor
signaling
Growth factors are polypeptide molecules
that elicit several responses in target cells.
These responses include proliferation, dif-
ferentiation, survival, and apoptosis of the
cells. A large number of growth factors are
known to bind syndecans through their hep-
aran sulfate chains (37), including members
of the fibroblast growth factor (FGF) family.
FGF binds to the extracellular domain of its
receptor, which is a transmembrane mole-
cule with protein-tyrosine kinase activity in
the cytoplasmic region. After growth factor
binding, the dimerization of the receptor
occurs, followed by autophosphorylation of
the intracellular domain of the receptor. This
process will initiate a signal transduction
cascade which will generate signals that reach
the nucleus, activating the expression of spe-
cific genes and leading to the cellular re-
sponse (Figure 3).
As co-receptors, syndecans increase the
local concentrations of growth factors and
promote receptor dimerization (3). Heparan
sulfate proteoglycan mediates the binding of
FGF to its high affinity receptor, which has
tyrosine kinase activity (13). Syndecan-4
over-expression enhances FGF-2 signaling,
and chimeric receptors composed of the
syndecan-4 cytoplasmic domain and hepa-
ran sulfate-substituted extracellular domains
enhance the cellular response to FGF, but
this is not the case for chimeras lacking the
cytoplasmic domain (38,39), a fact implying
the importance of syndecan-4 cytoplasmic
domain-mediated PKC activation in FGF
signaling. In contrast, there is no clear evi-
dence for syndecan-2 regulation of FGF sig-
naling in fibroblasts. However, syndecan-2
in activated human macrophages can selec-
tively bind FGF-2, vascular endothelial
growth factor and heparin-binding endothe-
lial growth factor. These results imply a key
role for syndecan-2 in the delivery of se-
questered growth factors by inflammatory
macrophages for productive binding to their
appropriate target cells in vivo (37).
In addition to FGF, syndecans-2 and -4
participate in the regulation of other growth
factors. It has been suggested that syndecan-
4 regulates protein levels of the endothelial
growth factor receptor (erb-B2 and -B3) in a
colon cancer cell line (40). Functional inter-
actions between syndecan-2 and GM-CSF
in osteoblasts have been suggested; perhaps
syndecan-2 also plays a role as a co-receptor
for this cytokine (41). Moreover, syndecan-
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2 can bind and regulate the signaling of
tumor growth factor-ß, and the binding is
through the ectodomain of the core protein,
with the heparan sulfate chains having only
a minor role. The binding is independent of
the cytoplasmic domain (42).
Syndecan-1 is also implicated in growth
factor signaling. Hepatocyte growth factor
binding to syndecan-1 promotes activation
of PI3-kinase and mitogen-activated protein
kinase pathways. Soluble syndecan-1 ap-
pears to act as a carrier for hepatocyte growth
factor in vivo and has been implicated in the
pathology of myeloma by modulating cy-
tokine activity within the bone marrow (43).
Syndecan-1, over-expressed on 3T3 cells
has been shown to inhibit FGF-2 signaling.
Syndecan-1 induction in S115 mammary
carcinoma cells can prevent the androgen-
induced transformation of these cells and
this can be accomplished by adding the
soluble ectodomain of syndecan-1 from nor-
mal NMuMG mammary epithelial cells, sug-
gesting disruption of an autocrine signaling
pathway that may involve FGF-2, FGF-8 or
other heparin-binding growth factors (44).
Members of the FGF family mediate, at
least in part, the outgrowth of the mesoderm
of the developing limb bud in response to the
apical ectodermal ridge. It has been shown
that syndecan-3 plays an essential role in
this process, mediating the interaction of the
FGFs produced by the apical ectodermal
ridge with the underlying mesoderm of the
limb bud. In addition, syndecan-3 also is a
cell-surface receptor for heparin-binding
growth factor-associated molecule (HB-
GAM) and is implicated in the activity of
this molecule on neurite outgrowth. On the
other hand, it should be mentioned that HB-
GAM interacts with the heparan sulfate
chains of syndecan-3. Syndecan-3 is a re-
ceptor for HB-GAM which promotes neu-
rite outgrowth. This requires c-Src and Fyn
tyrosine kinase activity, and involves cor-
tactin and tubulin. All of these molecules co-
immunoprecipitate with the cytoplasmic do-
main of syndecan-3, suggesting the assem-
bly or activation of a tyrosine kinase-con-
taining cytoplasmic complex (38,45,46).
Furthermore, syndecans are shed from
cell surfaces via cleavage of their ectodomain.
Syndecan shedding releases the ectodomain
as a soluble regulatory macromolecule. Syn-
decan-1 and -4 ectodomains in wound fluids
bind to growth factors, proteases and prote-
ase inhibitors. FGF-2, which is dependent
on heparan sulfate for its activity, is inhib-
ited by binding to the glycosaminoglycan of
the soluble syndecan-1 ectodomain. Cleav-
age of these heparan sulfate chains by physi-
ological heparinase produces soluble frag-
ments that greatly enhance FGF-2 activity.
Thus, it is not known under what circum-
stances a proteoglycan may be inhibitory or
stimulatory to growth factor signaling (22,
47).
Heparan sulfate chains and cell
signaling
Ligand binding was once thought to be a
relatively nonspecific ionic interaction be-
tween negatively charged heparin and hepa-
ran sulfate and positively charged domains
of proteins. However, many ligands require
specific sequences of well-defined length
and structure. Nowadays, several lines of
evidence suggest that the structural pecu-
liarities may be related to heparan sulfate
functions. As already mentioned, heparan
sulfate proteoglycans are present on the cell
surface of mammalian cells in culture and in
most vertebrate and invertebrate tissues (1,
2,9).
The advance of the chemistry and biol-
ogy and the increasing knowledge of the
physicochemical properties of heparin and
heparan sulfate have permitted us to clearly
distinguish between these two types of gly-
cosaminoglycans. This identification is based
on a number of criteria, including structural
characteristics, cellular localization and an-
ticoagulant activity (Table 1). Heparan sul-
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fates are composed of alternating units of α-
D-glucosamine and uronic acid (ß-D-glucu-
ronic or α-L-iduronic acid) and the hex-
osamine is either N-acetylated or N-sulfated
and/or 6-O-sulfated. Uronic acid can also be
2-O sulfated. The heparan sulfates exhibit a
peculiar structural variability (degree of N-
sulfation/N-acetylation and 6-O-sulfation as
well as the ratio of glucuronic acid and
iduronic acid) according to the tissue and
species of origin. Sequence analyses of hep-
aran sulfates have shown that all of them are
co-polymers consisting of several oligosac-
charide regions with distinct disaccharide
composition (Figure 4). These differences
could explain, for example, the preferential
binding of growth factors to some cells but
not to others.
The action of heparan sulfate chains as
positive modulators of cell proliferation is
due to the capacity of the compound to bind
and act as a co-receptor for growth factors.
They potentiate the action of low concentra-
tions of growth factor by enhancing the for-
mation of growth factor-receptor complexes.
Sulfated oligosaccharides obtained from
heparin and heparan sulfate potentiate the
mitogenic activity of FGF-1 on 3T3 fibro-
blasts. Although heparan sulfates extracted
from several mammalian tissues potentiated
the mitogenic activity of FGF-1, in general,
they were less efficient than heparin on a
mass basis. On the other hand, an oligosac-
charide obtained from heparan sulfate after
digestion with heparitinase I is more active
than the intact molecule, reaching a potenti-
ating effect equivalent to that of heparin,
whereas an N-acetylated oligosaccharide iso-
lated after nitrous acid degradation is inac-
tive. The results indicate that the mitogenic
activity of FGF-1 is primarily potentiated
through the interaction of more sulfated re-
gions of the heparan sulfate chains as well as
the presence of conformationally flexible
iduronic acid residues. Curiously, heparan
sulfate prepared from 3T3-conditioned cul-
ture medium proved to be more efficient
Table 1. Comparison of heparin and heparan sulfate.
Parameter Heparin Heparan sulfate
Potassium acetate (2 M, pH 5.7, 4ºC) Insoluble Soluble
Band formation in electrofocusing + -
Electrophoretic mobility (agarose)
Barbital 1.0 0.7
Diaminopropane 1.0 1.0
Barium - diaminopropane 1.0 2.0
Metachromatic activity (nm) 505 525
Sulfate/hexosamine ratios 2.4-2.8a 0.8-1.8b
Anticoagulant activity (USP/mg) 60-320 <5c
Degradation
Heparinase + less than 5%d
Heparitinase I - +
Heparitinase II + +
Cellular localization
Granules + -
Cell surface - +
Extracellular matrix - +
Binding
Antithrombin + less than 5%
Growth factors + +
Data from aRef. 48, bRef. 2, cRef. 49; dheparan sulfate obtained from endothelial cells
in culture is degraded by heparinase to the extent of 20% (Ref. 50).
Figure 4. Proposed general structure of heparan sulfate and sites of cleavage of heparitinase
I, heparitinase II, heparinase, and nitrous acid (for details, see Ref. 15). GlcNAc = 2-
acetamido α-D-glucopyranose; GlcNAc,6S = 2-acetamido α-D-glucopyranose-6-O-sulfate;
GlcNS = 2-N-sulfoamino α-D-glucopyranose; GlcNS,6S = 2-N-sulfoamino α-D-glucopyra-
nose-6-O-sulfate; GlcUA = ß-D-glucopyranosyl uronic acid; IdoUA = α-L-idopyranosyl
uronic acid; IdoUA,2S = α-L-idopyranosyl uronic acid 2-O-sulfate.
than heparin both on a mass and molar basis.
These results suggest that there is specificity
for this interaction, favoring the structural
specificity of this process (14). In this re-
gard, it has been shown that N-sulfate groups
and saccharides containing iduronic acid 2-
O-sulfate are essential for the high affinity
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binding of human skin fibroblast heparan
sulfate to FGF-2 and the sequence of an
oligosaccharide with similar affinity for the
growth factor as the parent molecule has
been determined (51).
It has been demonstrated that N-sulfate
groups are most important, followed by 2-O-
and 6-O-sulfate groups, for binding to neu-
regulin-1 (NRG-1) and blocking erbB re-
ceptor phosphorylation. Inhibition of sulfa-
tion through the use of chlorate or selective
blockade of N-sulfation with a siRNA di-
rected against the enzyme that promotes N-
sulfation resulted in decreased NRG-1-in-
duced erbB receptor activation. This speci-
ficity provides a means by which tissues can
localize and potentiate NRG-1 signaling
through modifications in glycosaminogly-
can composition (52).
Recently, it has been shown that the bind-
ing of endostatin to endothelial heparan sul-
fate shows a differential requirement for
specific sulfate groups. The results indicate
that 6-O-sulfates play a dominant role in
selectivity and 2-O-sulfates are not strictly
essential (53).
Using chlorate-treated rat mammary fi-
broblasts, FGF-2 and heparin-derived oli-
gosaccharides, dependence on the size of the
fragment was demonstrated for the stimulus
of DNA synthesis and phosphorylation of
p42/44 mitogen-activated protein kinase.
However, tetra- to octa-saccharides were less
potent in proliferation assays than deca- and
longer oligosaccharides. Furthermore, there
was no correlation between the binding pa-
rameters and the potency of the oligosaccha-
rides in DNA synthesis assays (54).
The phorbol ester, phorbol 12-myristate
13-acetate (PMA), was first known for its
tumor-promoting activity, and only later was
it recognized as a strong and specific activa-
tor of PKC, mimicking the natural modula-
tor of this enzyme, i.e., diacylglycerol. We
have reported that PMA specifically stimu-
lates the synthesis of heparan sulfate proteo-
glycan from endothelial cells, an effect that
is likely to be mediated by PKC activation.
Staurosporine, a potent kinase inhibitor, abol-
ishes the effect of PMA, whereas activation
of the cAMP/PKA pathway by both forsko-
lin and/or 8-BrcAMP is not effective in trig-
gering stimulation of heparan sulfate proteo-
glycan (syndecan-4) synthesis. Furthermore,
18-h PMA pre-treatment, that presumably
down-regulates PKC, renders endothelial
cells resistant to a second PMA treatment.
The most remarkable aspect of these results,
however, was the correlation between stim-
ulation of heparan sulfate proteoglycan syn-
thesis and the blockade of G1-S phase transi-
tion, both triggered by PMA (55,56). The
combination of orto-phenyl-ß-D-xylosides
with PMA produced some cumulative ef-
fect. PMA stimulates the synthesis of hepa-
ran sulfate mainly at the G1 phase, whereas
the greatest enhancement of synthesis pro-
duced by the xylosides is in the S phase of
the endothelial cell cycle (57).
Future directions
The post-genomic research era has started
through proteomic approaches that include
the post-translational modifications of pro-
teins. One important point is that the diver-
sity of the proteome may be determined by
sugars and phosphorylation. In all studies
referred to here, the data clearly indicate that
the glycosylation of specific proteins lead-
ing to the biosynthesis of syndecans plays
major roles in development, differentiation
and oncogenesis. The genes involved in the
biosynthetic pathway of the heparan sulfate
chains are expressed in a manner specific for
organs, tissues and cells. Therefore, their
activities may differ completely depending
on the site of their expression, as well as in
pathological conditions such as cancer. Sev-
eral intriguing biological functions have been
demonstrated for heparan sulfate by the anal-
ysis of mutants of model organisms and
manipulation of genes encoding biosynthetic
enzymes. For example, in Drosophila, mu-
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tations have been identified in the homo-
logue of UDP-D-glucose dehydrogenase,
which produces UDP-glucuronic acid (sug-
arless, sgl) (58) and in the N-deacetylase/N-
sulfotransferase homologue (sulfateless, sfl)
(59). In either sgl or sf l mutant embryos,
Wingless (Wg), a member of the Wnt fam-
ily, FGF and Hedgehog (Hh) signaling path-
ways are impaired. The phenotype associ-
ated with these mutations is severe and cor-
responds to complete loss of activity of these
pathways, indicating that the heparan sul-
fates are essential for signaling of growth
factors and morphogens. Mouse embryos
homozygous for a mutation in the gene cod-
ing for heparan sulfate 2-O-sulfotransferase,
also present multiple developmental abnor-
malities including lack of kidney induction.
The abnormalities are probably due to com-
promised activities of heparan sulfate and
growth factors in organogenesis (60).
As already noted, heparan sulfate chains
are consistently found in members of the
family of transmembrane proteoglycans,
known as syndecans. Syndecans participate
in a variety of physiological processes. They
appear at the early stages of development,
and the glycosaminoglycan chains vary ac-
cording to the tissue and species of origin.
Structural modifications are found in dis-
eases, especially in neoplastic transforma-
tion. Recent advances in syndecan research
suggest that the core proteins of these pro-
teoglycans are involved in many signaling
functions that translate information to the
cytosol from binding events of their heparan
sulfate chains during developmental pro-
cesses. The mechanism by which syndecans
can act as co-receptors with integrins re-
mains unknown, but recent studies point to
the syndecan extracellular protein domains,
that appear to complement the binding inter-
actions of their attached heparan sulfate
chains. Syndecan-4 can also interact with
PKC and stimulate its activity. The synde-
cans modulate the actions of a wide variety
of heparan sulfate-binding proteins.
Understanding the mechanisms by which
the syndecans participate in signal transduc-
tion pathways and questions addressing the
manner in which the enzymes related to the
biosynthesis of these compounds are located
in the cell or in the Golgi complex, what kind
of cluster they form, and how they actually
synthesize the sugar chain, are the new fron-
tier for this area, and may lead to novel
therapeutic strategies for the control of tu-
mor cell invasion and metastasis.
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